{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:55:42Z","timestamp":1791179742611,"version":"4.1.0"},"reference-count":19,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2003,11,28]],"date-time":"2003-11-28T00:00:00Z","timestamp":1069977600000},"content-version":"vor","delay-in-days":2249,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tropical Med Int Health"],"published-print":{"date-parts":[[1997,10]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Dengue virus infections have been well known for many years; still dengue virus is regarded as an \u2018emerging\u2019 pathogen, as the disease profile is changing. Its geographical range and oveall incidence, and the incidence of the associated complications, dengue haemorrhagic fever (DHF) and dengue shock syndrome (DSS), are on the increse. Modern\u2010day travel and increasing urbanization seem to be the main contributing factors. In order to estimate the risk of infection during long\u2010term stays in dengue\u2010endemic countries, we tested sera obtained from 323 development aid workers and their family members who had spent on average 9.8 years in dengue\u2010endemic regions for the presence of dengue virus antibodies.<\/jats:p><jats:p>Dengue virus antibody screening was done by a commercially available immunofluorescence test (IF). Reactive samples were re\u2010tested by an in\u2010house IF and also tested for cross\u2010reactivity to yellow fever virus using yellow fever IF and neutralization test (NT). Evaluation of the results revealed that the screening test has a specificity of at least 63.2%. In 12 of 19 initially positive cases crossreacting antibodies against yellow fever virus could be ruled out. Three cases remained indeterminable, whereas four of the reactive and 10 (out of 12) of the borderline reactive cases showed crossreactivity with yellow fever virus, probably due to previous vaceination.<\/jats:p><jats:p>We found seroprevalence rates of 4.3% with no significant differences related to gender or area of upbringing. Scroprevalence rates were evaluated according to region of suspected or confirmed infection. In two cases the dengue infection had taken a classical clinical course; in another three cases an extraordinary febrile illness was reported in the history. None of the other seropositive individuals had a history of an illness possibly attributable to dengue virus infection. Our results show that there definitely is a risk for long\u2010term expatriates to acquire (mostly non\u2010 or oligo\u2010symptomatic) dengue infection, which might be important especially in the light of the supposed aetiology of DHF or DSS as a secondary infection with another dengue virus serotype.<\/jats:p>","DOI":"10.1046\/j.1365-3156.1997.d01-149.x","type":"journal-article","created":{"date-parts":[[2010,10,29]],"date-time":"2010-10-29T18:59:09Z","timestamp":1288378749000},"page":"934-940","source":"Crossref","is-referenced-by-count":24,"title":["Emerging viral pathogens in long\u2010term expatriates (II): dengue virus"],"prefix":"10.1111","volume":"2","author":[{"given":"Th.","family":"J\u00e4nisch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Preiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Niedrig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Mikulicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Thoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. W.","family":"Doerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"issue":"3","key":"e_1_2_1_2_1","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1128\/iai.36.3.1036-1041.1982","article-title":"Infection enhancement of dengue type 2 virus in the U\u2010937 human monocyte cell line by antibodies to flavivirus crossreactive determinants","volume":"36","author":"Brandt WE","year":"1982","journal-title":"Infectious Immunology"},{"key":"e_1_2_1_3_1","first-page":"21","article-title":"Dengue type 3 infection \u2010 Nicaragua and Panama, October \u2010 November 1994","volume":"44","author":"Centers for Disease Control and Prevention","year":"1995","journal-title":"Morbidity and Mortality Weekly Report"},{"issue":"2","key":"e_1_2_1_4_1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3201\/eid0102.952004","article-title":"Dengue\/Dengue Hemorrhagic Fever: The Emergence of a Global Health Problem","volume":"1","author":"Gubler DJ","year":"1995","journal-title":"Emerging Infectious Disease"},{"key":"e_1_2_1_5_1","first-page":"383","article-title":"Emergence of epidemic dengue\/dengue hemorrhagic fever as a public health problem in the Americas","volume":"2","author":"Gubler DJ","year":"1994","journal-title":"Infectious Agents and Disease"},{"issue":"2","key":"e_1_2_1_6_1","first-page":"292","article-title":"The XXth century dengue pandemic: need for surveillance and research","volume":"45","author":"Halstead SB","year":"1992","journal-title":"World Health statistics quarterly WHO report"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.146.1.201"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/265739a0"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.302.6780.828"},{"key":"e_1_2_1_10_1","unstructured":"JaspertR.Iage\u2010StehrJ NiedrigMet al.(1996)Verbesserung der Fr\u00fchdiagnostik von Denguevirus\u2010Infektionen Typ 1\u20134 nach Fernreisen. Abstracr Jahresragung der Deutschen Gesellschaft f\u00fcr Virologie Jena M\u00e4rz 1996 p.225."},{"issue":"1","key":"e_1_2_1_11_1","first-page":"24","article-title":"Hemorrhagic dengue in Cuba: history of an epidemic","volume":"20","author":"Kouri G","year":"1986","journal-title":"Bulletin of the Pan American Health Organization"},{"key":"e_1_2_1_12_1","unstructured":"LeDucJW(1994)Global situation of Dengue fever. World Health Organization Regional Office for Western Pacific Report (WP) CDS (o) \/ICP\/OCD\/003E Report Series Number RS\/94\/GF\/22 (JPN):24."},{"key":"e_1_2_1_13_1","first-page":"961","volume-title":"Fields Virology","author":"Monath TP","year":"1996"},{"key":"e_1_2_1_14_1","first-page":"493","article-title":"A simple method of estimating fifty percent endpoints","volume":"27","author":"Reed CJ","year":"1938","journal-title":"American Journal of Hygiene"},{"key":"e_1_2_1_15_1","first-page":"485","volume-title":"Principles and Practice of Clinical Virology","author":"Schouh BD","year":"1995"},{"issue":"36","key":"e_1_2_1_16_1","first-page":"1673","article-title":"Importiertes Dengue\u2010Fieber in der Schweiz \u2010 Hinweise f\u00fcr bislang unerkannt hohe Pr\u00e4valenz","volume":"125","author":"Settah SG","year":"1995","journal-title":"Schweizer Medizmische Wochenschrift"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.1980050403"},{"key":"e_1_2_1_18_1","volume-title":"Dengue hemorrhagic fever: Diagnosis, treatment and control.","author":"World Health Organization","year":"1986"},{"key":"e_1_2_1_19_1","volume-title":"Dengue and Dengue Hemorrhagic Fever in the Americas: Guidelines for Prevention and Control.","author":"World Health Organization","year":"1994"},{"key":"e_1_2_1_20_1","volume-title":"Dengue et dengue h\u00e9morrhagique.","author":"World Health Organization","year":"1996"}],"container-title":["Tropical Medicine &amp; International Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-3156.1997.d01-149.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-3156.1997.d01-149.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T07:34:30Z","timestamp":1698392070000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-3156.1997.d01-149.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,10]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[1997,10]]}},"alternative-id":["10.1046\/j.1365-3156.1997.d01-149.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-3156.1997.d01-149.x","archive":["Portico"],"relation":{},"ISSN":["1360-2276","1365-3156"],"issn-type":[{"value":"1360-2276","type":"print"},{"value":"1365-3156","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,10]]}}}